UnitedHealth Q2 Adjusted EPS Crushes Consensus at $6.38, Full-Year Guidance Raised and Buyback Target Doubled
UNH sits 91% above its 52-week low of $234.6.
Summary
UnitedHealth Group reported Q2 2026 adjusted EPS of $6.38, crushing the $4.90 consensus, and raised full-year adjusted EPS guidance to $19.50–$20.00. The company also doubled its share buyback target to at least $5 billion and lifted operating earnings and cash flow outlooks.
Key Events · Earnings and Guidance · UNH
-
Q2 Adjusted EPS Blowout
Adjusted EPS of $6.38 versus consensus of $4.90, driven by strong performance across UnitedHealthcare and Optum.
-
Full-Year Guidance Raised Significantly
2026 adjusted EPS outlook raised to $19.50–$20.00 from $17.75; operating earnings guidance increased to >$25.45B from >$24.0B.
-
Share Buyback Target Doubled
Full-year 2026 share repurchase target raised to at least $5.0B from ~$2.5B, with $4.0B already repurchased through mid-July.
-
Medical Care Ratio Improves Sharply
Medical care ratio fell to 86.7% from 89.4% YoY, reflecting benefit design changes, pricing discipline, and $860M in favorable prior period development.
Analysis · UNH · Finance
A massive Q2 beat sets the tone: adjusted EPS came in at $6.38, well above the $4.90 consensus, prompting a full-year 2026 adjusted EPS outlook raise to $19.50–$20.00 from $17.75. Operating earnings guidance jumped to over $25.45 billion, and the share repurchase target was doubled to at least $5 billion. The medical care ratio improved sharply to 86.7% from 89.4% a year ago, driven by pricing discipline and cost management. Cash flow from operations guidance was also hiked to roughly $24 billion. This is a clean, broad-based beat with significant upward revisions across all key metrics, reinforcing the turnaround narrative after a mixed Q1.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 43.2% of the 271 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.30%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UNH was trading at $447.99 on NYSE in the Finance sector, with a market capitalization of approximately $380.1B. The 52-week trading range was $234.60 to $434.30. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.